Matthew Gall
Chief Financial Officer · 2 filings · Latest: May 1, 2026
Kalaris Therapeutics, Inc.
Tango Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Financial Officer · 2 filings · Latest: May 1, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|